FDA pulls authorization for AstraZeneca COVID treatment, says it's ineffective against some variants

 The U.S. Food and Drug Administration pulled its emergency use authorization of a COVID-19 treatment, claiming multiple variants of the virus that causes the disease are rendering it ineffective. The FDA said in a Friday press release that AstraZeneca’s Evusheld preventative medicine “is not expected to provide protection against developing SARS-CoV-2

The variants in question "are projected to be responsible for more than 90% of current infections in the U.S.," the FDA said. The revocation of the use authorization will be maintained "until further notice by the Agency."

• The agency had already warned earlier this month that the treatment was likely increasingly ineffective against new forms of SARS-CoV-2.

https://justthenews.com/government/federal-agencies/fda-pulls-authorization-astrazeneca-covid-treatment-says-its